Opthea Stock (NASDAQ: OPT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 258.00 / 15.86K |
Day Range | - - - |
52 Wk Range | 1.60 - 4.40 |
Market Cap | $598.62M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 78 |
Short Interest | 0.06% |
Days to Cover | 7.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Opthea (NASDAQ:OPT) through any online brokerage.
Other companies in Opthea’s space includes: Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and Ironwood Pharmaceuticals (NASDAQ:IRWD).
Opthea has a consensus price target of $24.00.
The stock price for Opthea (NASDAQ: OPT) is $3.89 last updated September 23, 2024 at 7:00 AM EDT.
There are no upcoming dividends for Opthea.
Opthea’s FY earnings are confirmed for Friday, August 30, 2024.
There is no upcoming split for Opthea.
Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.